日本語 ・View as Markdown

Inhalation of H/O(66.7 %/33.3 %) mitigates depression-like behaviors in diabetes mellitus complicated with depression mice via suppressing inflammation and preventing hippocampal damage.

H₂/O₂（66.7%/33.3%）吸入による糖尿病合併うつ病マウスの抑うつ様行動抑制：炎症抑制と海馬保護を介したメカニズム

Abstract

Diabetes mellitus complicated with depression (DD) is a psychosomatic condition associated with cognitive impairment and elevated disability risk. Using a mouse model induced by intraperitoneal streptozotocin (150 mg/kg) and lipopolysaccharide (0.5 mg/kg), this study examined the effects of H2/O2 (66.7%/33.3%) inhalation administered for 7 consecutive days. Standard behavioral tests revealed marked reduction in depressive-like behaviors. ELISA measurements showed decreased inflammatory cytokine concentrations in both peripheral serum and hippocampal tissue. MRI and immunofluorescence analyses demonstrated recovery of hippocampal volume and suppression of A1 astrocyte activation. These findings indicate that H2/O2 inhalation exerts beneficial effects on DD-related behavioral and neuroinflammatory endpoints in this preclinical model.

Mechanism

H2 acts as a selective hydroxyl radical scavenger, reducing inflammatory cytokine levels in serum and hippocampal tissue while suppressing A1 astrocyte activation, thereby preserving hippocampal structural integrity in DD mice.

Bibliographic

Authors

Fan H, Shi Y, Liu H, Zuo X, Yang Y, Yin H, et al.

Journal

Biomed Pharmacother

Year

2024

PMID

39405908

DOI

10.1016/j.biopha.2024.117559

Tags

Delivery context

For inhalation applications of molecular hydrogen, the lower flammability limit (LFL) deserves careful handling. The classical 4% figure applies to closed-system mixtures; the practical inhalation-environment threshold is 10%. Even pure-hydrogen output (the UFL 75% paradox) passes through the flammable range at the air–gas boundary. High-concentration (66% / 100%) inhalers are documented in the Japanese Consumer Affairs Agency accident-information database and are not recommended.

Safety notes

See also:

• Inhalation concentration and LFL / UFL
• Consumer Affairs Agency accident cases
• LFL / UFL terminology
• Inhalation safety threshold lineage

Other papers on the same disease / condition

• Molecular hydrogen inhibits neuroinflammation and ameliorates depressive-like behaviors and short-term cognitive impairment in senescence-accelerated mouse prone 8 mice.
  2025 ・ Behav Brain Res ・ hydrogen-rich water ・ positive
• Hydrogen restores central tryptophan and metabolite levels and maintains mitochondrial homeostasis to protect rats from chronic mild unpredictable stress damage.
  2025 ・ Neurochem Int ・ inhalation ・ positive
• Hydrogen and Methane Detection in Breath in Response to Two Different Types of Dietary Fiber and Its Relationship to Postprandial Glucose Concentration in Obese Patients with Type 2 Diabetes and Normoglycemic Subjects.
  2025 ・ Nutrients ・ not specified ・ mixed
• Decoupling the mutual promotion of inflammation and oxidative stress mitigates cognitive decline and depression-like behavior in rmTBI mice by promoting myelin renewal and neuronal survival.
  2024 ・ Biomed Pharmacother ・ hydrogen-rich water ・ positive
• The Effect of 14-Day Consumption of Hydrogen-Rich Water Alleviates Fatigue but Does Not Ameliorate Dyspnea in Long-COVID Patients: A Pilot, Single-Blind, and Randomized, Controlled Trial.
  2024 ・ Nutrients ・ hydrogen-rich water ・ mixed
• A novel intervention of molecular hydrogen on the unbalance of the gut microbiome in opioid addiction: Experimental and human studies.
  2024 ・ Biomed Pharmacother ・ mixed routes ・ positive
• Therapeutic potential of hydrogen-rich water in zebrafish model of Alzheimer's disease: targeting oxidative stress, inflammation, and the gut-brain axis.
  2024 ・ Front Aging Neurosci ・ hydrogen-rich water ・ positive
• Molecular Hydrogen Mediates Neurorestorative Effects After Stroke in Diabetic Rats: the TLR4/NF-κB Inflammatory Pathway.
  2023 ・ J Neuroimmune Pharmacol ・ inhalation ・ positive